Previous 10 | Next 10 |
PolarityTE (PTE) soars 25% premarket after announcing preliminary topline data demonstrating that a randomized controlled trial evaluating treatment of Diabetic Foot Ulcers with SkinTE plus standard of care ((SOC)) vs SOC alone met the primary endpoint of wound closure at 12 weeks a...
Reports Peer-Reviewed Publication of Interim Results from Diabetic Foot Ulcer Trial in International Wound Journal PolarityTE, Inc. (Nasdaq: PTE) today announced preliminary topline data demonstrating that a multi-center randomized controlled trial evaluating treatment o...
PolarityTE, Inc. (Nasdaq: PTE) today announced that it will report results for the quarter ended March 31, 2021 by press release on Thursday, May 13, 2021 at approximately 4:00 p.m. Eastern Time. In addition, the Company will host a conference call and webcast with Q&A on Ma...
Like all microcap biotechs, PolarityTE is a very risky bet. But they have a product with the potential to revolutionize wound care. This is a giant addressable market. I go over the promise, the risks, recent trials, and future plans. For further details see: PolarityTE:...
The following slide deck was published by PolarityTE, Inc. in conjunction with their 2020 Q4 earnings call. For further details see: PolarityTE, Inc. 2020 Q4 - Results - Earnings Call Presentation
PolarityTE, Inc. (PTE) Q4 2020 Earnings Conference Call March 30, 2021 08:00 a.m. ET Company Representatives David Seaburg - Chief Executive Officer Richard Hague - President, Chief Operating Officer Jake Patterson - Interim Chief Financial Officer Rich Haerle - Vice President of Investor Rel...
PolarityTE (PTE) share up more than 5% premarket after the company posts fourth-quarter revenue that beat Wall Street estimates, helped by the strength in the company's SkinTE business.Total revenue in the fourth quarter more than doubled to $3.59M compared to the same period l...
PolarityTE (PTE): Q4 Operational cash burn of $4.82MRevenue of $3.59M (+144.2% Y/Y) beats by $0.69M.Shares -1.63% PM.Press Release For further details see: PolarityTE beats on revenue
Fourth Quarter Revenues of $3.59 million and Full Year 2020 Revenues of $10.13 million PolarityTE to host conference call and webcast today, March 30, 2021 at 8:00 a.m. ET PolarityTE, Inc. (Nasdaq: PTE) , a biotechnology company developing regenerative tissue pro...
Support.com (SPRT) +271% as Greenidge Generation Holdings to go public via merger with the company.Seneca Biopharma (SNCA) +30%.Cemtrex (CETX) +21%.Marker Therapeutics (MRKR) +19%.Acer Therapeutics (ACER) +19%.Kansas City Southern (KSU) +17% as Canadian Pacific to buy the company fo...
News, Short Squeeze, Breakout and More Instantly...
(TheNewswire) Mississauga, ON - TheNewswire - M ay 30 , 202 3 - Pioneering Technology Corp. ( TSXV:PTE ) (“ Pioneering ” or the “ Company ”), a technology company and North America’s l...
(TheNewswire) Mississauga, ON – TheNewswire - May 5, 2023 - Pioneering Technology Corp. (“ Pioneering ” or the “ Company ”) (TSXV:PTE) , a technology company and North America's leader in cooking fire prevention technolo...
(TheNewswire) Mississauga, ON - TheNewswire - March 1, 2023 - Pioneering Technology Corp. ( TSXV:PTE ) (“ Pioneering ” or the “ Company ”), a technology company and North America’s leader in cooking fire prevention t...